SYNTHESIS AND CYTOTOXICITY OF POTENTIAL TUMOR-INHIBITORY ANALOGS OF TRIMELAMOL (2,4,6-TRIS[(HYDROXYMETHYL)METHYLAMINO]-1,3,5,-TRIAZINE) HAVING ELECTRON-WITHDRAWING GROUPS IN-PLACE OF METHYL

In exploring the structural features which determine the antitumor activity of 2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine (trimelamol (1)), we have synthesized analogues in which the methyl groups have been replaced by the electron-withdrawing substituents 2,2,2-trifluoroethyl (5), propargyl (13), and cyanomethyl (15) via the respective tris(alkylamino)triazines (3), (12) and (14). Three mono- [(hydroxymethyl)amino]triazines (4, 7, and 10) were also prepared. All the new tris(hydroxymethyl) derivatives showed cytotoxicities toward a variety of experimental rodent and human ovarian tumor cell lines similar to those shown by (1), the cyanomethyl analogue (15) having the most favorable profile. Mono(hydroxymethyl) derivatives (4 and 7) were ca. one-third as toxic. The new tris(hydroxymethyl) analogues were more stable to aqueous hydrolysis than was (1). Half-life (pH 7.5) values were, for (1), 120 min, for (5), 690 min, for (13), 450 min, for (15), 275 min, but at pH 2.0, (15) (t 1 /2 350 min) was the most stable. This cyanomethyl analogue was also the most water-soluble, being comparable to (1) whereas (5) and (13) were poorly soluble